- Both Wegovy and Mounjaro come in the form of injectable pens, which you use to deliver a weekly liquid injection of medication under the skin. Make sure you read the instructions for use that come with your medication or head here for more tips on how to safely and effectively use your injection pens.

- Clinical studies have shown that people can lose up to 22.5% of their weight when taking Mounjaro, and up to 15% of their weight when taking Wegovy.

• *Tirzepatide Once Weekly for the Treatment of Obesity, The New England Journal Of Medicine, 2022.
• ** Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial, Nature Medicine, 2024.

- The outer packaging is a plain, discreet and unbranded bag, with a cardboard box inside.

- Before your first use, store your injection pens in a refrigerator (2° C to 8° C) (making sure to keep away from the cooling element). After your first use, store below 30° C or, preferably, in a refrigerator (2° C to 8° C). Do not freeze Wegovy and do not use your medication if it has been frozen. When the pen is not in use, make sure to keep the pen cap on. Do not expose the pen to direct sunlight.

- Yes, both medicines are part of The Black Triangle Scheme. The Black Triangle (▼) Scheme is a program that monitors medicines for additional safety. Wegovy and Mounjaro are part of the scheme because they are new medicines, and the scheme means patients and prescribers are encouraged to report suspected adverse drug reactions (ADRs) to the MHRA through the Yellow Card Scheme MHRA website

- The registered healthcare provider for the Weight Management Programme is Blueco Healthcare. Medicines are prescribed by Pharmacist Independent Prescribers, you can find their details here

- Weight management medication is designed for long-term progress when teamed with lifestyle changes. You will start off taking the lowest dose of Wegovy and Mounjaro, once a week. HANX will follow up regularly with advice and guidance to help you settle into the weight management programme. You will have monthly follow-up consultations, which you'll be asked to complete to share your progress and experiences with your prescriber. If you are experiencing no major side effects, and your prescribing pharmacist deems it suitable for you, you will increase your dose of Wegovy or Mounjaro each month until you reach the most effective a 'maintenance' dose for you and check in with you regularly.

- Wegovy and Mounjaro, which are both GLP-1 medications that are clinically proven to help people lose weight*. Wegovy is the brand name for the medication ‘semaglutide’ and Mounjaro is the brand name for the medication ‘tirzepatide.’ A prescribing pharmacist will review your consultation and take into account your personal preference, medical history, and weight loss goals.. If they deem the medication to be safe and effective for you, they will prescribe Wegovy or Mounjaro taking into account your goals and preference of medication.